Stocktoria
Arcus Biosciences, Inc. RCUS
NYSE · stock · Pharmaceutical Preparations · website · IPO 2018-03-15
Arcus Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,763,113 | $148.7M | 7.79% |
| CITADEL ADVISORS LLC | 1,420,435 | $30.7M | 1.13% |
| RENAISSANCE TECHNOLOGIES LLC | 424,700 | $9.2M | 0.34% |
| TWO SIGMA INVESTMENTS, LP | 312,690 | $6.8M | 0.25% |
| D. E. Shaw & Co., Inc. | 259,400 | $5.6M | 0.21% |
| Point72 Asset Management, L.P. | 129,273 | $2.8M | 0.1% |
| AQR CAPITAL MANAGEMENT LLC | 86,294 | $1.9M | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.